Evidence map›Paper›PMID 41017052›Full record

ArticleEmerging infectious diseases2025

Multidrug-Resistant pESI-Harboring Salmonella enterica Serovar Muenchen Sequence Type 82 in Poultry and Humans, Israel, 2020-2023.

Janet Perry, Tal Rakler, Katya Arnold, Anat Wiseman, Cinthia Satuchne, Yaniv Pima, Galina Moiseeva, Ilana Maler, Eugenia Yakunin, Assaf Rokney and 1 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Janet Perry
Tal Rakler
Katya Arnold
Anat Wiseman
Cinthia Satuchne
Yaniv Pima
Galina Moiseeva
Ilana Maler
Eugenia Yakunin
Assaf Rokney
Ehud Elnekave

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salmonella enterica serovar Muenchen emerged in Israel in 2018 and became a major public health threat. We aimed to determine the role of poultry in rising human cases, transmission routes within the broiler industry, and genetic similarity to Salmonella Muenchen found globally. We used whole-genome sequencing to compare Salmonella Muenchen isolates from poultry, food, and humans collected in Israel (2020-2023; n = 109) and globally (n = 125). Salmonella Muenchen sequence type 82 isolates from Israel harbored pESI plasmid, exhibited high genetic similarity between human and poultry sources, and closely resembled international pESI-positive strains; we found quinolone-resistance determinants in 58.6% of isolates. Salmonella Muenchen prevalence in commercial broiler flocks was 61.5% (95% CI 51.5%-71.5%); strains could not be traced to breeder flocks, but on-farm persistence existed. The clonal spread of Salmonella Muenchen in poultry contributes to increased incidence in humans. Horizontal transmission in broilers requires control measures to protect public health.

Indexed as

Drug Resistance, Multiple, BacterialPoultry DiseasesSalmonella entericaSalmonella InfectionsSalmonella Infections, AnimalAnimalsAnti-Bacterial AgentsChickensHumansIsraelMicrobial Sensitivity TestsPoultrySerogroupWhole Genome SequencingAnti-Bacterial Agentsantimicrobial resistancebacteriafoodborne infectionsfood safetyhorizontal transmissionIsraelMDRmultidrug resistancepESI plasmidpoultrySalmonella Muenchensalmonellosiszoonoses

Identifiers

PMID41017052
PMCPMC12483013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.